Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis

Peter C. Grayson, Carmelo Carmona-Rivera, Lijing Xu, Noha Lim, Zhong Gao, Adam L. Asare, Ulrich Specks, John H. Stone, Philip Seo, Robert F. Spiera, Carol A. Langford, Gary S. Hoffman, Cees G M Kallenberg, E. William St. Clair, Nadia K. Tchao, Steven R Ytterberg, Deborah J. Phippard, Peter A. Merkel, Mariana J. Kaplan, Paul A. Monach

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Objective To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV. Methods The source of clinical data and linked biologic specimens was a randomized controlled treatment trial in AAV. RNA sequencing of whole blood from patients with AAV was performed during active disease at the baseline visit and during remission 6 months later. Gene expression was compared between patients who met versus those who did not meet the primary trial outcome of clinical remission at 6 months (responders versus nonresponders). Measurement of neutrophil-related gene expression was confirmed in peripheral blood mononuclear cells (PBMCs) to validate the findings in whole blood. A negative-selection strategy isolated LDGs from PBMC fractions. Results Differential expression between responders (n=77) and nonresponders (n=35) was detected in 2,346 transcripts at the baseline visit (P<0.05). Unsupervised hierarchical clustering demonstrated a cluster of granulocyte-related genes, including myeloperoxidase (MPO) and proteinase 3 (PR3). A granulocyte multigene composite score was significantly higher in nonresponders than in responders (P<0.01) and during active disease than during remission (P<0.01). This signature strongly overlapped an LDG signature identified previously in lupus (false discovery rate by gene set enrichment analysis <0.01). Transcription of PR3 measured in PBMCs was associated with active disease and treatment response (P<0.01). LDGs isolated from patients with AAV spontaneously formed neutrophil extracellular traps containing PR3 and MPO. Conclusion In AAV, increased expression of a granulocyte gene signature is associated with disease activity and decreased response to treatment. The source of this signature is likely LDGs, a potentially pathogenic cell type in AAV.

Original languageEnglish (US)
Pages (from-to)1922-1932
Number of pages11
JournalArthritis and Rheumatology
Volume67
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Antineutrophil Cytoplasmic Antibodies
Vasculitis
Granulocytes
Neutrophils
Gene Expression
Myeloblastin
Antibodies
Blood Cells
Therapeutics
Peroxidase
RNA Sequence Analysis
Information Storage and Retrieval
Genetic Association Studies
Transcriptome
Genes
Cluster Analysis
Randomized Controlled Trials
Biomarkers
Clinical Trials

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology

Cite this

Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis. / Grayson, Peter C.; Carmona-Rivera, Carmelo; Xu, Lijing; Lim, Noha; Gao, Zhong; Asare, Adam L.; Specks, Ulrich; Stone, John H.; Seo, Philip; Spiera, Robert F.; Langford, Carol A.; Hoffman, Gary S.; Kallenberg, Cees G M; St. Clair, E. William; Tchao, Nadia K.; Ytterberg, Steven R; Phippard, Deborah J.; Merkel, Peter A.; Kaplan, Mariana J.; Monach, Paul A.

In: Arthritis and Rheumatology, Vol. 67, No. 7, 01.07.2015, p. 1922-1932.

Research output: Contribution to journalArticle

Grayson, PC, Carmona-Rivera, C, Xu, L, Lim, N, Gao, Z, Asare, AL, Specks, U, Stone, JH, Seo, P, Spiera, RF, Langford, CA, Hoffman, GS, Kallenberg, CGM, St. Clair, EW, Tchao, NK, Ytterberg, SR, Phippard, DJ, Merkel, PA, Kaplan, MJ & Monach, PA 2015, 'Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis', Arthritis and Rheumatology, vol. 67, no. 7, pp. 1922-1932. https://doi.org/10.1002/art.39153
Grayson, Peter C. ; Carmona-Rivera, Carmelo ; Xu, Lijing ; Lim, Noha ; Gao, Zhong ; Asare, Adam L. ; Specks, Ulrich ; Stone, John H. ; Seo, Philip ; Spiera, Robert F. ; Langford, Carol A. ; Hoffman, Gary S. ; Kallenberg, Cees G M ; St. Clair, E. William ; Tchao, Nadia K. ; Ytterberg, Steven R ; Phippard, Deborah J. ; Merkel, Peter A. ; Kaplan, Mariana J. ; Monach, Paul A. / Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis. In: Arthritis and Rheumatology. 2015 ; Vol. 67, No. 7. pp. 1922-1932.
@article{3d505dcb99c142b596c5607d39268f9c,
title = "Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis",
abstract = "Objective To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV. Methods The source of clinical data and linked biologic specimens was a randomized controlled treatment trial in AAV. RNA sequencing of whole blood from patients with AAV was performed during active disease at the baseline visit and during remission 6 months later. Gene expression was compared between patients who met versus those who did not meet the primary trial outcome of clinical remission at 6 months (responders versus nonresponders). Measurement of neutrophil-related gene expression was confirmed in peripheral blood mononuclear cells (PBMCs) to validate the findings in whole blood. A negative-selection strategy isolated LDGs from PBMC fractions. Results Differential expression between responders (n=77) and nonresponders (n=35) was detected in 2,346 transcripts at the baseline visit (P<0.05). Unsupervised hierarchical clustering demonstrated a cluster of granulocyte-related genes, including myeloperoxidase (MPO) and proteinase 3 (PR3). A granulocyte multigene composite score was significantly higher in nonresponders than in responders (P<0.01) and during active disease than during remission (P<0.01). This signature strongly overlapped an LDG signature identified previously in lupus (false discovery rate by gene set enrichment analysis <0.01). Transcription of PR3 measured in PBMCs was associated with active disease and treatment response (P<0.01). LDGs isolated from patients with AAV spontaneously formed neutrophil extracellular traps containing PR3 and MPO. Conclusion In AAV, increased expression of a granulocyte gene signature is associated with disease activity and decreased response to treatment. The source of this signature is likely LDGs, a potentially pathogenic cell type in AAV.",
author = "Grayson, {Peter C.} and Carmelo Carmona-Rivera and Lijing Xu and Noha Lim and Zhong Gao and Asare, {Adam L.} and Ulrich Specks and Stone, {John H.} and Philip Seo and Spiera, {Robert F.} and Langford, {Carol A.} and Hoffman, {Gary S.} and Kallenberg, {Cees G M} and {St. Clair}, {E. William} and Tchao, {Nadia K.} and Ytterberg, {Steven R} and Phippard, {Deborah J.} and Merkel, {Peter A.} and Kaplan, {Mariana J.} and Monach, {Paul A.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/art.39153",
language = "English (US)",
volume = "67",
pages = "1922--1932",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis

AU - Grayson, Peter C.

AU - Carmona-Rivera, Carmelo

AU - Xu, Lijing

AU - Lim, Noha

AU - Gao, Zhong

AU - Asare, Adam L.

AU - Specks, Ulrich

AU - Stone, John H.

AU - Seo, Philip

AU - Spiera, Robert F.

AU - Langford, Carol A.

AU - Hoffman, Gary S.

AU - Kallenberg, Cees G M

AU - St. Clair, E. William

AU - Tchao, Nadia K.

AU - Ytterberg, Steven R

AU - Phippard, Deborah J.

AU - Merkel, Peter A.

AU - Kaplan, Mariana J.

AU - Monach, Paul A.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Objective To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV. Methods The source of clinical data and linked biologic specimens was a randomized controlled treatment trial in AAV. RNA sequencing of whole blood from patients with AAV was performed during active disease at the baseline visit and during remission 6 months later. Gene expression was compared between patients who met versus those who did not meet the primary trial outcome of clinical remission at 6 months (responders versus nonresponders). Measurement of neutrophil-related gene expression was confirmed in peripheral blood mononuclear cells (PBMCs) to validate the findings in whole blood. A negative-selection strategy isolated LDGs from PBMC fractions. Results Differential expression between responders (n=77) and nonresponders (n=35) was detected in 2,346 transcripts at the baseline visit (P<0.05). Unsupervised hierarchical clustering demonstrated a cluster of granulocyte-related genes, including myeloperoxidase (MPO) and proteinase 3 (PR3). A granulocyte multigene composite score was significantly higher in nonresponders than in responders (P<0.01) and during active disease than during remission (P<0.01). This signature strongly overlapped an LDG signature identified previously in lupus (false discovery rate by gene set enrichment analysis <0.01). Transcription of PR3 measured in PBMCs was associated with active disease and treatment response (P<0.01). LDGs isolated from patients with AAV spontaneously formed neutrophil extracellular traps containing PR3 and MPO. Conclusion In AAV, increased expression of a granulocyte gene signature is associated with disease activity and decreased response to treatment. The source of this signature is likely LDGs, a potentially pathogenic cell type in AAV.

AB - Objective To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV. Methods The source of clinical data and linked biologic specimens was a randomized controlled treatment trial in AAV. RNA sequencing of whole blood from patients with AAV was performed during active disease at the baseline visit and during remission 6 months later. Gene expression was compared between patients who met versus those who did not meet the primary trial outcome of clinical remission at 6 months (responders versus nonresponders). Measurement of neutrophil-related gene expression was confirmed in peripheral blood mononuclear cells (PBMCs) to validate the findings in whole blood. A negative-selection strategy isolated LDGs from PBMC fractions. Results Differential expression between responders (n=77) and nonresponders (n=35) was detected in 2,346 transcripts at the baseline visit (P<0.05). Unsupervised hierarchical clustering demonstrated a cluster of granulocyte-related genes, including myeloperoxidase (MPO) and proteinase 3 (PR3). A granulocyte multigene composite score was significantly higher in nonresponders than in responders (P<0.01) and during active disease than during remission (P<0.01). This signature strongly overlapped an LDG signature identified previously in lupus (false discovery rate by gene set enrichment analysis <0.01). Transcription of PR3 measured in PBMCs was associated with active disease and treatment response (P<0.01). LDGs isolated from patients with AAV spontaneously formed neutrophil extracellular traps containing PR3 and MPO. Conclusion In AAV, increased expression of a granulocyte gene signature is associated with disease activity and decreased response to treatment. The source of this signature is likely LDGs, a potentially pathogenic cell type in AAV.

UR - http://www.scopus.com/inward/record.url?scp=84933055926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933055926&partnerID=8YFLogxK

U2 - 10.1002/art.39153

DO - 10.1002/art.39153

M3 - Article

C2 - 25891759

AN - SCOPUS:84933055926

VL - 67

SP - 1922

EP - 1932

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -